Cohorts |  | QOL score on 0–10 scale N (%) |  | ||
---|---|---|---|---|---|
 | Missing | <=5 | >5 to <8 | 8-10 | Total |
Advanced cancer | 7 | 25 (21%) | 30 (25%) | 65 (54%) | 120 |
Brain cancer | 0 | 8 (31%) | 11 (42%) | 7 (27%) | 26 |
Breast cancer | 0 | 27 (9%) | 94 (32%) | 175 (59%) | 296 |
Clinical trial lung cancer | 0 | 236 (20%) | 350 (30%) | 569 (49%) | 1155 |
Colon cancer pts-2 wks post surgery (Colectomy) | 63 | 67 (17%) | 118 (30%) | 203 (52%) | 388 |
Colon cancer pts-pre surgery (Colectomy) | 48 | 58 (14%) | 85 (21%) | 260 (65%) | 403 |
GI cancer | 0 | 287 (12%) | 682 (28%) | 1440 (60%) | 2409 |
GU cancer | 0 | 14 (8%) | 41 (23%) | 125 (69%) | 180 |
Gynecologic cancer | 0 | 14 (12%) | 35 (30%) | 68 (58%) | 117 |
Head and neck cancer | 0 | 54 (21%) | 78 (31%) | 122 (48%) | 254 |
Hematologic cancer | 0 | 4 (13%) | 13 (41%) | 15 (47%) | 32 |
Lymphatic cancer | 0 | 2 (25%) | 1 (13%) | 5 (63%) | 8 |
Multiple site cancer | 0 | 0 (0%) | 5 (36%) | 9 (64%) | 14 |
Musculoskeletal site cancer | 0 | 6 (33%) | 5 (28%) | 7 (39%) | 18 |
Neurologic cancer | 0 | 25 (12%) | 75 (35%) | 114 (53%) | 214 |
Other cancer | 0 | 8 (15%) | 8 (15%) | 36 (69%) | 52 |
Lung cancer- Mayo study | 0 | 137 (26%) | 143 (27%) | 249 (47%) | 529 |
Lung cancer- Mayo study 6 months post diagnosis | 0 | 326 (23%) | 426 (30%) | 657 (47%) | 1409 |
Skin cancer | 0 | 0 (0%) | 4 (57%) | 3 (43%) | 7 |
Unknown site cancer | 0 | 10 (34%) | 9 (31%) | 10 (34%) | 29 |
Healthy NCCTG volunteers | 0 | 1 (2%) | 12 (22%) | 41 (76%) | 54 |
Hospice caregivers | 4 | 9 (17%) | 23 (43%) | 21 (40%) | 53 |
Hospice | 5 | 22 (42%) | 23 (44%) | 7 (13%) | 52 |
Minnesota medical students | 2 | 84 (15%) | 202 (37%) | 257 (47%) | 543 |
Mayo physicians | 5 | 58 (13%) | 174 (38%) | 228 (50%) | 460 |
Mayo residents | 0 | 83 (28%) | 125 (42%) | 87 (29%) | 295 |
Advanced cancer –psychosocial study | 0 | 10 (23%) | 24 (55%) | 10 (23%) | 44 |